Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2021 Feb;10(5):e019452.
doi: 10.1161/JAHA.120.019452. Epub 2021 Feb 15.

Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New-Onset Heart Failure

Erin McGuinn  1   2 , Theodore Warsavage  1 , Mary E Plomondon  1   2   3 , Javier A Valle  1   2   3 , P Michael Ho  1   2 , Stephen W Waldo  1   2   3
Affiliations
Multicenter Study

Association of Ischemic Evaluation and Clinical Outcomes Among Patients Admitted With New-Onset Heart Failure

Erin McGuinn et al. J Am Heart Assoc. 2021 Feb.

Abstract

Background The significant morbidity associated with systolic heart failure makes it imperative to identify patients with a reversible cause. We thus sought to evaluate the proportion of patients who received an ischemic evaluation after a hospitalization for new-onset systolic heart failure. Methods and Results Patients admitted with a new diagnosis of heart failure and a reduction in left ventricular ejection fraction (≤40%) were identified in the VA Healthcare System from January 2006 to August 2017. Among those who survived 90 days without a readmission, we evaluated the proportion of patients who underwent an ischemic evaluation. We identified 9625 patients who were admitted with a new diagnosis of systolic heart failure with a concomitant reduction in ejection fraction. A minority of patients (3859, 40%) underwent an ischemic evaluation, with significant variation across high-performing (90th percentile) and low-performing (10th percentile) sites (odds ratio, 3.79; 95% CI, 2.90-4.31). Patients who underwent an evaluation were more likely to be treated with angiotensin-converting enzyme inhibitors (75% versus 64%, P<0.001) or beta blockers (92% versus 82%, P<0.001) and subsequently undergo percutaneous (8% versus 0%, P<0.001) or surgical (2% versus 0%, P<0.001) revascularization. Patients with an ischemic evaluation also had a significantly lower adjusted hazard of all-cause mortality (hazard ratio, 0.54; 95% CI, 0.47-0.61) compared with those without an evaluation. Conclusions Ischemic evaluations are underutilized in patients admitted with heart failure and a new reduction in left ventricular systolic function. A focused intervention to increase guideline-concordant care could lead to an improvement in clinical outcomes.

Keywords: coronary artery disease; ischemic evaluation; revascularization; systolic heart failure.

PubMed Disclaimer

Conflict of interest statement

Dr Valle receives unrelated consulting fees from Philips Medical, Medtronic, and Cardiovascular Systems Incorporated. Dr Ho is supported by grants from NHLBI, VA HSR&D, and University of Colorado School of Medicine. He has a research agreement with Bristol‐Myers Squibb through the University of Colorado. He serves as the Deputy Editor for Circulation: Cardiovascular Quality and Outcomes. Dr Waldo receives unrelated investigator‐initiated research support from Abiomed, Cardiovascular Systems Incorporated, Merck Pharmaceuticals, Janssen Pharmaceuticals, and the National Institutes of Health. The remaining authors have no disclosures to report.

Figures

Figure 1
Figure 1. Cohort construction.
Figure 2
Figure 2. Temporal trends in admissions for heart failure with reduced ejection fraction, showing the number of patients admitted with and without an ischemic evaluation as well as the proportion (line) stratified by time.
Figure 3
Figure 3. Mortality among propensity‐weighted patients admitted with heart failure and reduced ejection fraction, stratified by an ischemic evaluation.
The hazard ratio (HR) for mortality was reduced 46% (HR, 0.54; 95% CI, 0.47–0.61) among patients with an ischemic evaluation compared with those without an ischemic evaluation, with the comparison beginning 90 days after the index presentation to mitigate the immortal time bias.
Figure 4
Figure 4. Composite of mortality and rehospitalization for heart failure or myocardial infarction among propensity‐weighted patients admitted with heart failure and reduced ejection fraction, stratified by an ischemic evaluation.
The hazard ratio (HR) for the composite was reduced 31% (HR, 0.69; 95% CI, 0.64–0.75) among patients with an ischemic evaluation compared with those without an ischemic evaluation, with the comparison beginning 90 days after the index presentation to mitigate the immortal time bias.
See this image and copyright information in PMC

References

    1. Lloyd‐Jones DM, Larson MG, Leip EP, Beiser A, D’Agostino RB, Kannel WB, Murabito JM, Vasan RS, Benjamin EJ, Levy D; Framingham Heart Study . Lifetime risk for developing congestive heart failure: the Framingham Heart Study. Circulation. 2002;106:3068–3072. DOI: 10.1161/01.CIR.0000039105.49749.6F. - DOI - PubMed
    1. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, et al.; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee . Heart disease and stroke statistics‐2018 update: a report from the American Heart Association. Circulation. 2018;137:e67–e492. - PubMed
    1. Anderson HV, Weintraub WS, Radford MJ, Kremers MS, Roe MT, Shaw RE, Pinchotti DM, Tcheng JE. Standardized cardiovascular data for clinical research, registries, and patient care: a report from the Data Standards Workgroup of the National Cardiovascular Research Infrastructure project. J Am Coll Cardiol. 2013;61:1835–1846. DOI: 10.1016/j.jacc.2012.12.047. - DOI - PMC - PubMed
    1. Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, Ikonomidis JS, Khavjou O, Konstam MA, Maddox TM, et al.; American Heart Association Advocacy Coordinating Committee, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Radiology and Intervention, Council on Clinical Cardiology, Council on Epidemiology and Prevention, Stroke Council . Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6:606–619. DOI: 10.1161/HHF.0b013e318291329a. - DOI - PMC - PubMed
    1. Ling LF, Marwick TH, Flores DR, Jaber WA, Brunken RC, Cerqueira MD, Hachamovitch R. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium. Circ Cardiovasc Imaging. 2013;6:363–372. DOI: 10.1161/CIRCIMAGING.112.000138. - DOI - PubMed

Publication types

LinkOut - more resources